Portfolio Archive

iStock 931409422
Patient Content
DeLene Beeland

FDA Approves First Generic of Restasis

The U.S. Food and Drug Administration (FDA) has approved the first generic of Restasis© (cyclosporine ophthalmic emulsion) eye drops to increase tear production in people with chronic dry eye (CDE). Why is a generic product good

COMM coronell lab 738x491 400x266 1
Academic Content
DeLene Beeland

Can Sustainable Plastics Clean Our Plastics-Polluted Waters?

Inventing a new kind of plastic to remove plastic pollution from our drinking water may sound counterintuitive. But for Frank Leibfarth, PhD, it makes perfect sense. Leibfarth, an assistant professor of chemistry, invented a synthetic resin

Ep clinical surgery underused 2
Patient Content
DeLene Beeland

Is Epilepsy Surgery Underused in Adults?

About 3 in every 10 people with epilepsy will find that anti-seizure drugs do not bring relief. Plus, it may take 1 to 2 years of treatments to know whether medicine helps. Uncontrolled epilepsy may interfere with your

iStock 1270933857
Patient Content
DeLene Beeland

What Is Cibinqo® (abrocitinib)?

Cibinqo® (abrocitinib) is a daily medicine for moderate to severe atopic dermatitis. Atopic dermatitis is also known as eczema. Cibinqo is useful for adults with atopic dermatitis that has not responded well to other drugs or biologics.

iStock 1252840886
Patient Content
DeLene Beeland

What Is Rinvoq® (upadacitinib)?

Rinvoq® (upadacitinib) is a drug for moderate to severe atopic dermatitis, or eczema. It is useful for people who are unable to take other medicines, therapies, or biologics for atopic dermatitis, or those who have not responded

iStock 1374573261
Patient Content
DeLene Beeland

Susvimo® (ranibizumab)

Susvimo® (ranibizumab injection) is approved to treat people with wet age-related macular degeneration (AMD) who have previously responded to at least 2 anti-vascular endothelial growth factor (VEGF) injections. Susvimo is a 2-part system that includes an eye

iStock 1217908833
Patient Content
DeLene Beeland

Vabysmo® (faricimab)

Vabysmo® (faricimab) is approved to treat people with wet age-related macular degeneration (AMD) who have previously responded to at least 2 injections of an endothelial growth factor (VEGF) inhibitor into the eye. In people with wet AMD,

iStock 1146672844
Patient Content
DeLene Beeland

Comparing Spinraza® and Evrysdi®: Things to Consider

If you are taking Spinraza® (nusinersen) for spinal muscular atrophy (SMA), then you may be curious about Evrysdi® (risdiplam). Both therapies are available in the United States, but there are a few things to consider when comparing

SDn living children causes
Patient Content
DeLene Beeland

Narcolepsy in Kids: Are They Born With It?

Narcolepsy often begins in childhood or adolescence. But it can look a lot different in kids than in adults. This can make it hard for doctors to diagnose children with narcolepsy. There are 2 types of